Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilan Goldenberg

Showing results (441-450 of 484) with videos related to

Pageof 49
Sort By:
European Heart Journal|November 16, 2010
Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRTAlon Barsheshet, Ilan Goldenberg, Arthur J Moss, et al.
Heart Rhythm|August 2, 2021
Use of oral contraceptives in women with congenital long QT syndromeIlan Goldenberg, Arwa Younis, David T Huang, et al.
The American Journal of Cardiology|May 23, 2022
Comparison of Frequency of Ventricular Tachyarrhythmia in Men-Versus-Women in Patients with Implantable Cardioverter-Defibrillator for Primary PreventionAmole Ojo, Arwa Younis, Shireen Saxena, et al.
Journal of Cardiovascular Electrophysiology|July 15, 2023
Effect of sodium glucose cotransporter 2 inhibitors on atrial tachy-arrhythmia burden in patients with cardiac implantable electronic devicesArwa Younis, Tania Arous, Robert Klempfner, et al.
JACC. Heart Failure|July 2, 2026
Implantable Cardioverter-Defibrillator Therapy in Contemporary Heart Failure Patients: An Analysis From the EMPEROR-Reduced TrialMehmet K Aktaş, Khawaja M Talha, Ilan Goldenberg, et al.
Science Translational Medicine|April 1, 2011
Use of mutant-specific ion channel characteristics for risk stratification of long QT syndrome patientsChristian Jons, Jin O-Uchi, Arthur J Moss, et al.
Journal of the American College of Cardiology|November 17, 2012
In silico cardiac risk assessment in patients with long QT syndrome: type 1: clinical predictability of cardiac modelsRyan Hoefen, Matthias Reumann, Ilan Goldenberg, et al.
JACC. Clinical Electrophysiology|June 23, 2022
Reduction in Ventricular Tachyarrhythmia Burden in Patients Enrolled in the RAID TrialArwa Younis, Ilan Goldenberg, Shamroz Farooq, et al.
JACC. Clinical Electrophysiology|November 30, 2023
Sex-Related Differences in Ventricular Tachyarrhythmia Events in Patients With Implantable Cardioverter-Defibrillator and Prior Ventricular TachyarrhythmiasBartosz Krzowski, Valentina Kutyifa, Margot Vloka, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 12, 2020
Sex-Specific Platelet Activation Through Protease-Activated Receptors Reverses in Myocardial InfarctionBeom Soo Kim, David S Auerbach, Hamza Sadhra, et al.
Pageof 49

Showing results (441-450 of 484) with videos related to

Sort By:
Pageof 49
European Heart Journal|November 16, 2010
Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRTAlon Barsheshet, Ilan Goldenberg, Arthur J Moss, et al.
Heart Rhythm|August 2, 2021
Use of oral contraceptives in women with congenital long QT syndromeIlan Goldenberg, Arwa Younis, David T Huang, et al.
The American Journal of Cardiology|May 23, 2022
Comparison of Frequency of Ventricular Tachyarrhythmia in Men-Versus-Women in Patients with Implantable Cardioverter-Defibrillator for Primary PreventionAmole Ojo, Arwa Younis, Shireen Saxena, et al.
Journal of Cardiovascular Electrophysiology|July 15, 2023
Effect of sodium glucose cotransporter 2 inhibitors on atrial tachy-arrhythmia burden in patients with cardiac implantable electronic devicesArwa Younis, Tania Arous, Robert Klempfner, et al.
JACC. Heart Failure|July 2, 2026
Implantable Cardioverter-Defibrillator Therapy in Contemporary Heart Failure Patients: An Analysis From the EMPEROR-Reduced TrialMehmet K Aktaş, Khawaja M Talha, Ilan Goldenberg, et al.
Science Translational Medicine|April 1, 2011
Use of mutant-specific ion channel characteristics for risk stratification of long QT syndrome patientsChristian Jons, Jin O-Uchi, Arthur J Moss, et al.
Journal of the American College of Cardiology|November 17, 2012
In silico cardiac risk assessment in patients with long QT syndrome: type 1: clinical predictability of cardiac modelsRyan Hoefen, Matthias Reumann, Ilan Goldenberg, et al.
JACC. Clinical Electrophysiology|June 23, 2022
Reduction in Ventricular Tachyarrhythmia Burden in Patients Enrolled in the RAID TrialArwa Younis, Ilan Goldenberg, Shamroz Farooq, et al.
JACC. Clinical Electrophysiology|November 30, 2023
Sex-Related Differences in Ventricular Tachyarrhythmia Events in Patients With Implantable Cardioverter-Defibrillator and Prior Ventricular TachyarrhythmiasBartosz Krzowski, Valentina Kutyifa, Margot Vloka, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 12, 2020
Sex-Specific Platelet Activation Through Protease-Activated Receptors Reverses in Myocardial InfarctionBeom Soo Kim, David S Auerbach, Hamza Sadhra, et al.
Pageof 49